Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Unsettled expectations: how recent patent decisions affect biotech

A look back shows that broad patents are a thing of the past and biotech inventors face heightened requirements for patentability.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bilski v. Kappos, 561 US ___ (2010).

  2. 23 USC §101.

  3. Prometheus Laboratories, Inc. v. Mayo Collaborative Services, No. 2008-1403 (Fed. Cir. Dec. 17, 2010).

  4. Classen Immunotherapies, Inc. v. Biogen IDEC, Nos. 2006-1634 and 2006-1649 (Fed. Cir. 2008).

  5. Association for Molecular Pathology v. USPTO and Myriad Genetics, Inc., No. 2010-1406 (Fed. Cir. 2010).

  6. In re Fisher, 421 F.3d 1365 (Fed. Cir. 2005).

  7. In re Gleave, 560 F.3d 1331 (Fed. Cir. 2009).

  8. Schering Corp. v. Geneva Pharm., Inc., 339 F.3d 1373 (Fed. Cir. 2003).

  9. KSR Int'l Co. v. Teleflex, Inc., 550 U.S. 398 (2007).

  10. In re Kubin, 561 F.3d 1351 (Fed. Cir. 2009).

  11. USPTO BPAI, Foundation of Taxpayer & Consumer Rights v. Patent of WARF, Appeal 2010-001854, Patent 7,029,913 (April 28, 2010).

  12. Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., 598 F.3d 1336 (Fed. Cir. 2010) (en banc).

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Brenda M Simon or Christopher T Scott.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simon, B., Scott, C. Unsettled expectations: how recent patent decisions affect biotech. Nat Biotechnol 29, 229–230 (2011). https://doi.org/10.1038/nbt.1795

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.1795

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research